Pluri Inc PLUR

Healthcare Biotechnology

Pluri Inc., formerly known as Pluristem Therapeutics Inc., is an Israel-headquartered company engaged in the research and provision of cell-based products directed for a range of industries. The Company is focused on researching and developing cell transformation and 3D cell expansion technologies that allow mass production of cells. The products of the Company are used for the pharmaceutical industry as well as for food technology, agriculture technology, and cell-based materials. In the pharmaceutical sector, the Company's preclinical and clinical programs explore multiple therapeutic areas such as vascular disease, inflammation-related conditions, muscle injuries, and hematological disorders. In the food sector, the Firm produces cultivated meat, cultivated fish, and seafood, as well as plant-based products. In agriculture, the Company develops alternative farming methods. The Company has a portfolio of over 140 granted patents in approximately 52 countries.

NDAQ:PLUR - Post by User

Pluri Inc

<< Previous

Bullboard Posts

Next >>

Post by lucaM1on May 09, 2022 9:25am

74 Views

Post# 34666381

$PSTI among the 5 Biotech Penny Stocks Redditors Love

Pluristem Therapeutics Inc. (NASDAQ:PSTI) is a biotech firm specializing in cell therapeutic products and related technologies. In early January, the stock jumped more than 30% after the company announced that it would be partnering with Tnuva Group, one of the largest food producers in Israel, for the development and launch of cultured cell-based products for the food industry. The latter is expected to invest over $7 million in the project with the option to invest double this amount within twelve months.

Some other projects that Pluristem Therapeutics Inc. (NASDAQ:PSTI) is working on include research related to the potential of PLX cell therapies in preventing and treating medical conditions caused during space missions.
Among the hedge funds being tracked by Insider Monkey, New York-based investment firm ARK Investment Management is a leading shareholder in Pluristem Therapeutics Inc. (NASDAQ:PSTI), with 1 million shares worth more than $1.5 million.

https://www.insidermonkey.com/blog/5-biotech-penny-stocks-redditors-love-1041208/2/